CDR1 Polyclonal Antibody

Autoantibodies directed against the protein encoded by this intronless gene have been found in some patients with paraneoplastic cerebellar degeneration. The encoded protein contains several hexapeptide repeats.

The CDR1 Polyclonal Antibody is a highly specific and sensitive immunological reagent designed for the detection and quantification of the Complementarity Determining Region 1 (CDR1) of immunoglobulin molecules. This antibody is produced by immunizing animals with synthetic peptides corresponding to the CDR1 region of human immunoglobulin heavy chains. The resulting polyclonal antibody exhibits high affinity and specificity towards the CDR1 region of various immunoglobulin isotypes, including IgG, IgM, and IgA.

The CDR1 Polyclonal Antibody is suitable for a wide range of applications in immunological research, including Western blotting, ELISA, immunohistochemistry, and flow cytometry. It can be used to detect and quantify the expression levels of CDR1 in various biological samples, such as serum, plasma, tissue lysates, and cell culture supernatants.

This antibody is supplied as a purified IgG fraction, which has been affinity-purified from the serum of immunized animals. It is provided in a liquid format, which is ready-to-use for most applications. The CDR1 Polyclonal Antibody is highly stable and can be stored at -20°C for long-term storage.

In summary, the CDR1 Polyclonal Antibody is a reliable and versatile tool for the detection and quantification of CDR1 in various immunological applications. Its high specificity and sensitivity make it an ideal reagent for researchers studying the structure and function of immunoglobulin molecules.